AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
GlaxoSmithKline works to bring flu vaccine to U.S. market.
Byline: Linda Loyd
Oct. 12--GlaxoSmithKline P.L.C. is in talks with the U.S. Food and Drug Administration about selling its Fluarix influenza vaccine in the United States this season because of the expected flu vaccine shortage this year.
"We are in ongoing discussions with FDA about the possibility of bringing Fluarix to the U.S.," Danielle Halstrom, spokeswoman for the London-based drug maker said.
Glaxo is exploring ways to supply doses this season, and working on a long-term plan to increase production at its main flu vaccine manufacturing plant in Dresden, Germany, she said. The drug maker would not say how many flu vaccine doses it makes, or how much it could ...
- Chiron Corp., one of only two major makers of the flu vaccine for the United...
- Magazine article from: McKnight's Long-Term Care News August 1, 2005 700+ words
Chiron Corp., one of only two major makers of the flu vaccine for the United States, cut its 2005 output forecast due to continuing problems with its Liverpool, England, factory. The company plans to produce...
- Nasally administered flu vaccine comes to United States.(Brief Article)
- Newspaper article from: Sports Medicine Reports Elliott, William T. August 1, 2003 700+ words
The FDA has approved the first nasally administered flu vaccine to be marketed in Medimmune's "FluMist" is also the first influenza vaccine to use live virus. This year's version of the...
- FDA recommends changes for next flu vaccine.(NEWS)(United States Food and Drug...
- Magazine article from: Internal Medicine News Mechcatie, Elizabeth March 15, 2009 700+ words
...influenza B strain in the current influenza vaccine in the United States should be replaced for the 2009-2010 influenza vaccine...date, influenza A (H1N1) viruses have predominated in the United States and many other countries. Most of the viruses have been...
- CDC to test Novavax' flu vaccine.(United States. Centers for Disease Control...
- Newspaper article from: Pharma Marketletter November 13, 2006 700+ words
USA-based infectious disease specialist Novavax says that the Centers for Disease Control and Prevention (CDC) has agreed to undertake assessment of its H5N1 influenza vaccine candidate against live bird flu virus. Under the terms of the deal, Novavax will provide the CDC with a supply of its
- United States finds flu vaccine it hopes to buy abroad.
- Newspaper article from: Knight Ridder/Tribune Business News October 29, 2004 700+ words
...government had found 5 million doses of flu vaccine in Germany and Canada that it will attempt...administration's efforts to modernize flu vaccine manufacturing. "Simply put," Thompson...more reliable system for developing flu vaccine and other immunizations date to the...
- United States to import more flu vaccine, says health department chief.
- Newspaper article from: Atlanta Journal-Constitution (Atlanta, GA) December 7, 2004 700+ words
...Secretary Tommy Thompson will announce as early as today that the United States will purchase influenza vaccine made for Canada and Europe...said Monday. "We do have optimism that additional doses of flu vaccine can be purchased," Dr. Julie Gerberding told the American...
- United States : CPL Biologicals to build new flu vaccine plant.
- News wire article from: TendersInfo October 29, 2009 700+ words
...venture between biotechnology company Novavax Inc. and Cadila Pharmaceuticals Ltd., said Wednesday that it is building a new flu vaccine manufacturing plant in India. The 25,000 square foot facility is targeted to be running within four months, with 60 million...
- United States imports flu vaccine.
- Newspaper article from: Daily News (NY, NY) December 8, 2004 700+ words
Byline: Paul H.B. Shin Dec. 8--As many as 4 million doses of the flu shot will be imported from Germany to alleviate the vaccine shortage, regulators said yesterday, but people getting them will have to sign forms accepting the unlicensed vaccine's health risks. GlaxoSmithKline, maker of the
